nach oben

Forensic Toxicology

Erschienen in:

03.11.2019 | Letter to the Editor

Surface adsorption of cannabinoids in LC–MS/MS applications

verfasst von: Jon B. Stephenson, Denise N. Carter, Mario Richardson

Erschienen in: Forensic Toxicology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor …

Chu MHC, Drummer OH (2002) Determination of ∆ ⁹-THC in whole blood using gas chromatography-mass spectrometry. J Anal Toxicol 26:575–581. https://doi.org/10.1093/jat/26.8.575 CrossRefPubMed

Roth KDW, Siegel NA, Johnson RW Jr, Litauszki L, Salvati L Jr, Harrington CA, Wray LK (1996) Investigation of the effects of solution composition and container material type on the loss of 11-nor ∆ ⁹-THC-9-carboxylic acid. J Anal Toxicol 20:291–300. https://doi.org/10.1093/jat/20.5.291 CrossRefPubMed

Dugan S, Bogema S, Schwartz RW, Lappas NT (1994) Stability of drugs of abuse in urine samples stored at − 20 °C. J Anal Toxicol 18:391–396. https://doi.org/10.1093/jat/18.7.391 CrossRefPubMed

Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza AJ (1993) Adsorption losses from urine-based cannabinoid calibrators during routine use. Clin Chem 39:1705–1712 (PMID:8394791) PubMed

Bond GD, Chand PC, Walia AS, Liu RH, Ogden SD (1990) Observation of reduced concentration of ∆ ⁹-THC-carboxylic acid in urine specimen containers using internal barcode labels. J Anal Toxicol 14:389–390. https://doi.org/10.1093/jat/14.6.389 CrossRefPubMed

Dextraze P, Griffiths WC, Camara P, Audette L, Rosner M (1989) Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability. Ann Clin Lab Sci 19:133–138 (PMID: 2546480) PubMed

Christophersen AS (1986) Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. J Anal Toxicol 10:129–131. https://doi.org/10.1093/jat/10.4.129 CrossRefPubMed

Fenimore DC, Davis CM, Whitford JH, Harrington CA (1976) Vapor phase silylation of laboratory glassware. Anal Chem 48:2289–2290. https://doi.org/10.1021/ac50008a065 CrossRef

Garrett ER, Hunt CA (1974) Physicochemical properties, solubility, and protein binding of ∆ ⁹-tetrahydrocannabinol. J Pharm Sci 63:1056–1064. https://doi.org/10.1002/jps.2600630705 CrossRefPubMed

10.

Jamerson MH, McCue JJ, Klette KL (2005) Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-∆ ⁹-tetrahydrocannabinol-9-carboxylic acid. J Anal Toxicol 29:627–631. https://doi.org/10.1093/jat/29.7.627 CrossRefPubMed

11.

Welsh ER, Snyder JJ, Klette KL (2009) Stabilization of urinary THC solutions with a simple non-ionic surfactant. J Anal Toxicol 33:51–55. https://doi.org/10.1093/jat/33.1.51 CrossRefPubMed

12.

Joerm WA (1987) Detection of past and recurrent marijuana use by a modified GC/MS procedure. J Anal Toxicol 11:49–52. https://doi.org/10.1093/jat/11.2.49 CrossRef

13.

Joern WA (1992) Surface adsorption of the urinary marijuana carboxy metabolite: the problem and a partial solution. J Anal Toxicol 16:401. https://doi.org/10.1093/jat/16.6.401 CrossRefPubMed

14.

United Chemical Technologies (2009) Delta 9-THC (parent), delta 9-hydroxy THC, carboxy-delta 9-THC in whole blood for GC/MS confirmation using: 200 mg clean screen^® extraction column. United Chemicals Technologies, Bristol

15.

Jamey C, Szwarc E, Tracqui A, Ludes B (2008) Determination of cannabinoids in whole blood by UPLC-MS-MS. J Anal Toxicol 32:349–354. https://doi.org/10.1093/jat/32.5.349 CrossRefPubMed

16.

Coulter C, Miller E, Crompton K, Moore C (2008) Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol 32:653–658. https://doi.org/10.1093/jat/32.8.653 CrossRefPubMed

17.

Øiestad EL, Johansen U, Øiestad ÅML, Christophersen AS (2011) Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 35:280–293. https://doi.org/10.1093/anatox/35.5.280 CrossRefPubMed

Titel: Surface adsorption of cannabinoids in LC–MS/MS applications
verfasst von: Jon B. Stephenson
Denise N. Carter
Mario Richardson
Publikationsdatum: 03.11.2019
Verlag: Springer Singapore
Erschienen in: Forensic Toxicology / Ausgabe 1/2020
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI: https://doi.org/10.1007/s11419-019-00505-x

Neu im Fachgebiet Rechtsmedizin

01.04.2024 | Forensische Traumatologie | CME

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Surface adsorption of cannabinoids in LC–MS/MS applications

Excerpt

Neu im Fachgebiet Rechtsmedizin

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Pharmacokinetics, pharmacodynamics, and toxicity of the new psychoactive substance 3,4-dimethylmethcathinone (3,4-DMMC)

Identification of new NBOH drugs in seized blotter papers: 25B-NBOH, 25C-NBOH, and 25E-NBOH

In vivo and in vitro metabolism of the novel synthetic cannabinoid 5F-APINAC

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives: phase I and II metabolism, plasma protein binding, and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry

Pharmacokinetic study of xylazine in a zebrafish water tank, a human-like surrogate, by liquid chromatography Q-Orbitrap mass spectrometry

Neu im Fachgebiet Rechtsmedizin

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien